These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD. Yang KC, Fang CC, Su TC, Lee YT. Am J Kidney Dis; 2005 Mar; 45(3):e57-60. PubMed ID: 15754265 [Abstract] [Full Text] [Related]
6. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides. Schulze F, Glos S, Petruschka D, Altenburg C, Maas R, Benndorf R, Schwedhelm E, Beil U, Böger RH. Nutr Res; 2009 May; 29(5):291-7. PubMed ID: 19555809 [Abstract] [Full Text] [Related]
10. Bridging the gap in treatment options for patients with hypertriglyceridemia. Underberg JA, Hays R. J Fam Pract; 2007 Dec; 56(12 Suppl New):S24-31. PubMed ID: 18664339 [Abstract] [Full Text] [Related]
11. Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia. Avisar I, Brook JG, Wolfovitz E. Eur J Intern Med; 2008 May; 19(3):203-8. PubMed ID: 18395165 [Abstract] [Full Text] [Related]
12. Effects of bezafibrate on HDL2/HDL3 ratio in postmenopausal hypertriglyceridemic women. Ushiroyama T, Sakuma K, Nosaka S. J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):142-8. PubMed ID: 16891292 [Abstract] [Full Text] [Related]
13. [Treatment of essential hypertension and hypercholesterolemia with or without hypertriglyceridemia, with low dose of bezafibrate (200 mg/day)]. Cruz J, Cruzera AB, Marcondes M, Cruz HM. Rev Hosp Clin Fac Med Sao Paulo; 1990 Jun; 45(5):201-4. PubMed ID: 2133171 [Abstract] [Full Text] [Related]
14. Heparin treatment for severe hypertriglyceridemia in diabetic ketoacidosis. Cole RP. Arch Intern Med; 2009 Aug 10; 169(15):1439-41. PubMed ID: 19667310 [Abstract] [Full Text] [Related]
18. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K. Indian Heart J; 2008 Aug 10; 60(3):215-22. PubMed ID: 19240310 [Abstract] [Full Text] [Related]
19. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers. Penn R, Williams RX, Guha-Ray DK, Sawyers WG, Braun SL, Rains KT. Clin Ther; 2006 Jan 10; 28(1):45-54. PubMed ID: 16490579 [Abstract] [Full Text] [Related]
20. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin. Fujita N, Kaito M, Kai M, Sugimoto R, Tanaka H, Horiike S, Konishi M, Iwasa M, Watanabe S, Adachi Y. J Viral Hepat; 2006 Jul 10; 13(7):441-8. PubMed ID: 16792537 [Abstract] [Full Text] [Related] Page: [Next] [New Search]